Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis
Authors
Keywords
C5a, C5a receptor, Prognosis, Lymph node metastasis, Proliferation
Journal
Breast Cancer
Volume 23, Issue 6, Pages 876-885
Publisher
Springer Nature
Online
2015-10-22
DOI
10.1007/s12282-015-0654-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?
- (2014) W. F. Anderson et al. JNCI-Journal of the National Cancer Institute
- CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways
- (2014) Tammy Sobolik et al. MOLECULAR BIOLOGY OF THE CELL
- Molecular tests as prognostic factors in breast cancer
- (2014) Marc J. van de Vijver VIRCHOWS ARCHIV
- Mutation of POLB Causes Lupus in Mice
- (2014) Alireza G. Senejani et al. Cell Reports
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
- (2013) H. Nitta et al. CLINICAL CANCER RESEARCH
- Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
- (2013) Jie Gu et al. LUNG CANCER
- The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
- (2013) Xiaoyang Ling et al. PLoS One
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer
- (2012) Mutsuko Yamamoto-Ibusuki et al. MODERN PATHOLOGY
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression
- (2010) Xiaojuan Sun et al. Molecular Cancer
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society
- (2009) Hirotaka Iwase et al. Breast Cancer
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started